intermediate-risk prostate cancer

March 18, 2019

Some PC Patients Can Safely Receive Short but Intense Course of Radiation

News

Stereotactic body radiotherapy (SBRT), which delivers higher doses of radiation over a significantly shorter period of time, can be safely given to men with low- or intermediate-risk prostate cancer with similar ... Read more

December 13, 2018

10-Year Survival of Young Low- and Intermediate-risk Prostate Cancer Patients Better with Radiation than Surgery

News

Radiation therapy approaches — including brachytherapy and external beam radiation therapy (EBRT) — lead to better 10-year survival rates than prostate surgery in young patients with low- and intermediate-risk prostate ... Read more

November 1, 2018

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

News

Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as the ... Read more

June 2, 2017June 2, 2017

Medicare Expands Coverage of Prolaris, Genetic Test for Prostate Cancer Aggressiveness

News

Medicare coverage for Prolaris genetic test, a tool developed by Myriad Genetics to help predict the aggressiveness of prostate, cancer has been expanded to include patients with favorable intermediate-risk cancer. Men with low- ... Read more

March 21, 2017March 21, 2017

Compressing 8-Week Radiation Therapy into 4 Weeks Just as Effective in Treating Localized Prostate Cancer

News

Four weeks of radiation therapy at larger doses has the same effect as conventional radiation therapy administered to prostate cancer patients over eight weeks, according to results from a Phase 3 ... Read more

October 4, 2016

Intermediate Risk Prostate Cancer May Be Safely Controlled with Brachytherapy Alone

News

Patients with prostate cancer who receive brachytherapy alone have similar cancer control rates and fewer side effects compared to those who receive brachytherapy in combination with external beam therapy (EBT), according ... Read more

September 29, 2016September 29, 2016

Precision Radiotherapy, SBRT, Shows Promise as 1st Treatment for Low- and Medium-Risk Prostate Cancers

News

Men newly diagnosed with low- or intermediate-risk prostate cancer may benefit more by being treated with high-dose stereotactic body radiotherapy (SBRT) as a first therapy than with other available radiotherapies, according to ... Read more